Ocugen, Inc. Research And Development Expense

Quick Answer

Ocugen, Inc. reported Research And Development Expense of $39.75 million for the year ending 2025.

  • Ocugen, Inc. showed an increase of +23.7% in Research And Development Expense from 2024 to 2025.
  • This data is from Ocugen, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2014 to 2025), Ocugen, Inc.'s Research And Development Expense has grown by 52.7%.
  • Historical annual values: Fiscal year 2025: $39.75 million | Fiscal year 2024: $32.13 million | Fiscal year 2023: $39.57 million | Fiscal year 2019: $8.09 million | Fiscal year 2018: $10.32 million | Fiscal year 2017: $15.57 million | Fiscal year 2016: $21.58 million | Fiscal year 2015: $23.24 million | Fiscal year 2014: $26.04 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: